Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea and Erythropoietin in Thalassemia Intermedia
NCT01624038Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Jun 2012
- Primary completion
- Dec 2012
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in thalassemia intermedia (TI), sponsored by Ain Shams University. Status: unknown.
02
Drugs
epoetin alfa
03
Conditions
thalassemia intermedia (TI)
Beyond the preview
Go deeper on NCT01624038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01624038.